Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Boston Properties

Edison

Dividend stocks have become investors' favorites in recent months. Tech turbulence and high-interest rates combined to make high-yield stocks an alternative to riskier equities while still beating the yield on fixed-income investments like treasuries.

3 Sorry Dividend Stocks to Sell in August Before It's Too Late

American Electric Power Company

EPR Properties

Energy Transfer LP Unit

Southern Company

Verizon

Walgreens

The writing could be on the wall, as the Moody's downgrade was poo-pooed by many across Wall Street as “late to the party.

Sell Any August Rally as September May Be a Disaster: 7 Safe-Haven Dividend Buys

Altria Group has a long history, and its subsidiaries focus on the manufacture and sale of cigarettes and tobacco products. The company has shown consistent profitability and a strong free cash flow margin, allowing for shareholder-friendly capital allocation. Despite substantial undervaluation, I do not expect a massive rally for the stock price due to secular headwinds, but the current forward dividend yield at 8.6% is a safe gift.

Altria: A Strong Buy For Dividend Investors

Diageo

Lockheed Martin

Molson Coors Brewing

Vici Properties

One category that some portfolio managers avoid discussing, especially in the ESG (environmental, social, governance) era, is the so-called sin stocks.

Worried About a Market Crash in the Fall? These 5 Dividend Sin Stocks to Buy Always Have Demand

Alibaba

QUALCOMM

Altria is managing the slow demise of the tobacco business in a way that will keep the cash flowing. Qualcomm is not a top-of-mind semiconductor name, but that's what makes it such a compelling bet.

3 Stocks to Buy at a Massive Discount Right Now

Altria Group has consistently increased profits and market share, offering attractive dividends and solidifying its position in the industry. Despite challenges in the tobacco industry, Altria Group has shown adaptability and resilience, reflected in its strategic pricing and strong dividend yield. Technical analysis suggests a long-term bullish trend for Altria Group, with potential investment opportunities during stock price corrections.

Altria Group: A Solid Buy Now (Technical Analysis)

Intuit

Virtus Investment Partners

After years of a low interest rate environment (though rates have been trending higher over the past year), many investors have turned to equities not only for the growth potential but also for solid and dependable dividends that help to provide an income stream.

Tech Giant One of 3 ‘Strong Buy' Blue Chip Stocks Likely Raising Dividends This Week

Altria's dividend is yielding 8.5% and is projected to grow by 4% annually for the next five years. The company has a clear path to growing its payout through price increases and share repurchases.

Could Altria's Dividend Continue to Grow?

Realty Income Corp

We've seen a wild ride this month, and we're barely a week into August. After stocks hitting a year-to-date peak on July 31st, each day in August saw another red close as markets pared back gains and institutional investors took profit.

The 3 Most Reliable Dividend Stocks to Buy for August 2023

Kohl's

LyondellBasell Industries

Prudential Financial

Starwood Property

The Moody's bank downgrades were poo-pooed by many across Wall Street as “late to the party.

There Is Still Time to Sell the 2023 AI Rally and Grab These 8 ‘Strong Buy' Big Dividend Giants

Arbor Realty Trust

PepsiCo

High-yield investments come with a certain degree of controversy. You're either getting a high yield because of high risk, or because of certain biases from the investment community. Here are 3 top high-yield investment ideas.

My 3 Top High Dividend Yield Picks (8-11% Yields)

Cardinal Health

Chubb

GlaxoSmithKline

Illinois Tool Works

Johnson Controls

Kimberly-Clark

Coca-Cola

Leggett & Platt

Mondelez

Philip Morris

July was exciting as ever as my year-over-year numbers continue to highlight the trifecta magic of dividend investing, which includes adding fresh capital, dividend raises and basic compounding to create an ever increasing passive income stream. I have to say I'm quite pleased with my July totals. Not too far from that coveted four-digit milestone too. After all, dividends don't lie. It's real cash being returned to investors. With patience and consistency these results and better can be achieved.

Dividend Income Update July 2023

Ares Capital

Banco de Chile

British American Tobacco

Eni SpA Sponsored ADR

Ecopetrol

Icahn Enterprises

MPLX

Pembina Pipeline

Petroleo Brasileiro

Stellantis N.V. 

AT&T

Telefonica SA

Vodafone Group

dogsofthedow.com (DOD) recently published this list of 50 large-cap high-dividend stocks as of 8/3/23 per data from YCharts. The DOD list targeted investors who “don't want to simply focus on a high dividend yield only to discover that the stock price has plunged or that the corporation has gone belly-up." Investors reduce this volatility/risk by searching for high dividends from large well-established companies. For example, YCharts net-gain estimates (updated 8/3/23) for STLA, PBA, ET, BTI, TEF, T, PBR, IEP, VOD & MO ranged 36.88%-65.73%.

50 Large-Cap High-Yield Stocks For August

Altria Group's adjusted diluted EPS payout ratio could expand slightly from 75.2% in 2022 to 76.3% in 2023. Brand strength and pricing power led revenue net of excise taxes and adjusted diluted EPS higher through the first half of the year. My inputs into the dividend discount model and discounted cash flows model imply the stock could be trading at a 33% discount to fair value.

Altria Group: Awaiting A Healthy Dividend Hike From This Dividend King

MO's ambitious NJOY marketing plan demonstrates its efficient supply chain and deep understanding of the US tobacco market. Every 1 point of gain in the smoke-free market may be equivalent to $35M in revenue opportunity, based on NJOY's 3.2% of market share and $115M in 2022 annual revenues. For now, MO continues to grow its profitability, thanks to the hiked prices despite the decline in volume.

Altria: Nears Accumulation Point Again - Long-Term Income Winner

Procter & Gamble

Altria's cigarette business is throwing off cash that the company is returning to investors via huge dividends. The number of cigarettes being sold is in steady decline.

Better Buy: Altria vs. Procter & Gamble

Altria reported Q2 earnings with EPS growing by 11% and revenue growing by 14% quarter-over-quarter. The company's focus is now on accelerating the adoption of NJOY, with plans to distribute to 43k stores in Q3 and 70k stores by the end of the year. Altria's balance sheet remains strong, with a debt to EBITDA ratio of 2.2x, and they have received $1.7 billion with interest from Phillip Morris.

Altria:(E)NJOY The Turnaround Story

Altria's cigarette business has a dominant position in the United States. The company is using this cash cow operation to pay investors big dividends.

3 Price Increases in 7 Months: Should Altria Shareholders Be Worried?

KeyCorp

Omega Healthcare Investors

OneMain Hld

Pioneer Natural Resources

Wall Street is giddy again after the S&P 500 burst out of the longest bear market in over 70 years in June and then tacked on another 15% in July.

Sell Any August Rallies and Move to 7 ‘Strong Buy' Analyst Favorites With Huge Dividends

Altria Group reaffirms guidance for 2023 fiscal year and remains a profitable powerhouse in the tobacco industry. MO demonstrates strong profitability and cash flow, with an increase in net earnings and free cash flow. The acquisition of NJOY Holdings expands MO's diversification and solidifies its position in the marketplace, positioning it for a non-combustible future.

Altria Group Looks Undervalued With A Dividend Exceeding 8%

AbbVie

ABM Industries

Black Hills

Colgate-Palmolive

"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the Dow. The 50 Dividend Kings screened as of July 28, 2023, represented nine of eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 13.68%-34.52% topped-by Target, and Gorman-Rupp. By yield, Altria tops-all. Top-ten Kingly August yields from NFG, ABBV, BKH, FRT, NWN, MMM, CDUAF, LEG, UVV, & MO averaged 5.24%.

Buy 5 August Dividend Kings, Watch 4 More

News for Altria Stock (MO)